Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Science, No. 440, Ji Yan Road, Jinan, 250017, China.
Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University, Jinan, China.
Eur Radiol. 2019 Jun;29(6):2958-2967. doi: 10.1007/s00330-018-5949-2. Epub 2019 Jan 14.
To determine the integrative value of clinical, hematological, and computed tomography (CT) radiomic features in survival prediction for locally advanced non-small cell lung cancer (LA-NSCLC) patients.
Radiomic features and clinical and hematological features of 118 LA-NSCLC cases were firstly extracted and analyzed in this study. Then, stable and prognostic radiomic features were automatically selected using the consensus clustering method with either Cox proportional hazard (CPH) model or random survival forest (RSF) analysis. Predictive radiomic, clinical, and hematological parameters were subsequently fitted into a final prognostic model using both the CPH model and the RSF model. A multimodality nomogram was then established from the fitting model and was cross-validated. Finally, calibration curves were generated with the predicted versus actual survival status.
Radiomic features selected by clustering combined with CPH were found to be more predictive, with a C-index of 0.699 in comparison to 0.648 by clustering combined with RSF. Based on multivariate CPH model, our integrative nomogram achieved a C-index of 0.792 and retained 0.743 in the cross-validation analysis, outperforming radiomic, clinical, or hematological model alone. The calibration curve showed agreement between predicted and actual values for the 1-year and 2-year survival prediction. Interestingly, the selected important radiomic features were significantly correlated with levels of platelet, platelet/lymphocyte ratio (PLR), and lymphocyte/monocyte ratio (LMR) (p values all < 0.05).
The integrative nomogram incorporated CT radiomic, clinical, and hematological features improved survival prediction in LA-NSCLC patients, which would offer a feasible and practical reference for individualized management of these patients.
• An integrative nomogram incorporated CT radiomic, clinical, and hematological features was constructed and cross-validated to predict prognosis of LA-NSCLC patients. • The integrative nomogram outperformed radiomic, clinical, or hematological model alone. • This nomogram has value to permit non-invasive, comprehensive, and dynamical evaluation of the phenotypes of LA-NSCLC and can provide a feasible and practical reference for individualized management of LA-NSCLC patients.
确定临床、血液学和计算机断层扫描(CT)放射组学特征在局部晚期非小细胞肺癌(LA-NSCLC)患者生存预测中的综合价值。
本研究首先提取和分析了 118 例 LA-NSCLC 患者的放射组学特征以及临床和血液学特征。然后,使用共识聚类方法结合 Cox 比例风险(CPH)模型或随机生存森林(RSF)分析自动选择稳定且具有预后意义的放射组学特征。随后,使用 CPH 模型和 RSF 模型将预测性放射组学、临床和血液学参数拟合到最终的预后模型中。然后,从拟合模型中建立多模态列线图并进行交叉验证。最后,通过预测与实际生存状态生成校准曲线。
聚类结合 CPH 选择的放射组学特征具有更好的预测性,其 C 指数为 0.699,而聚类结合 RSF 的 C 指数为 0.648。基于多变量 CPH 模型,我们的综合列线图在内部验证中的 C 指数为 0.792,在交叉验证中的保留率为 0.743,优于单独的放射组学、临床或血液学模型。校准曲线显示,1 年和 2 年生存率预测的预测值与实际值之间存在一致性。有趣的是,所选的重要放射组学特征与血小板、血小板/淋巴细胞比值(PLR)和淋巴细胞/单核细胞比值(LMR)水平显著相关(p 值均<0.05)。
整合 CT 放射组学、临床和血液学特征的综合列线图提高了 LA-NSCLC 患者的生存预测,为这些患者的个体化管理提供了一种可行且实用的参考。
构建并验证了一个整合 CT 放射组学、临床和血液学特征的综合列线图,以预测 LA-NSCLC 患者的预后。
综合列线图优于单独的放射组学、临床或血液学模型。
该列线图具有非侵入性、全面和动态评估 LA-NSCLC 表型的价值,并可为 LA-NSCLC 患者的个体化管理提供一种可行且实用的参考。